Folgen
Franck Madoux
Franck Madoux
Associate Director, Amgen
Bestätigte E-Mail-Adresse bei amgen.com
Titel
Zitiert von
Zitiert von
Jahr
Small-molecule proteostasis regulators for protein conformational diseases
B Calamini, MC Silva, F Madoux, DM Hutt, S Khanna, MA Chalfant, ...
Nature chemical biology 8 (2), 185-196, 2012
2492012
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
L Plate, CB Cooley, JJ Chen, RJ Paxman, CM Gallagher, F Madoux, ...
elife 5, e15550, 2016
2082016
Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1
Y Wang, DM Lonard, Y Yu, DC Chow, TG Palzkill, J Wang, R Qi, ...
Cancer research 74 (5), 1506-1517, 2014
1722014
Development of functionally selective, small molecule agonists at kappa opioid receptors
L Zhou, KM Lovell, KJ Frankowski, SR Slauson, AM Phillips, JM Streicher, ...
Journal of Biological Chemistry 288 (51), 36703-36716, 2013
1542013
Advanced development of primary pancreatic organoid tumor models for high-throughput phenotypic drug screening
S Hou, H Tiriac, BP Sridharan, L Scampavia, F Madoux, J Seldin, ...
SLAS DISCOVERY: Advancing Life Sciences R&D 23 (6), 574-584, 2018
1392018
Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases
Y Wang, RL Stowe, CE Pinello, G Tian, F Madoux, D Li, LY Zhao, JL Li, ...
Chemistry & biology 22 (2), 273-284, 2015
1002015
Endogenous and synthetic ABHD5 ligands regulate ABHD5-perilipin interactions and lipolysis in fat and muscle
MA Sanders, F Madoux, L Mladenovic, H Zhang, X Ye, M Angrish, ...
Cell metabolism 22 (5), 851-860, 2015
982015
Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists
M Doghman, J Cazareth, D Douguet, F Madoux, P Hodder, E Lalli
The Journal of Clinical Endocrinology & Metabolism 94 (6), 2178-2183, 2009
892009
A 1536-well 3D viability assay to assess the cytotoxic effect of drugs on spheroids
F Madoux, A Tanner, M Vessels, L Willetts, S Hou, L Scampavia, ...
SLAS DISCOVERY: Advancing Life Sciences R&D 22 (5), 516-524, 2017
742017
Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening
F Madoux, X Li, P Chase, G Zastrow, MD Cameron, JJ Conkright, ...
Molecular pharmacology 73 (6), 1776-1784, 2008
592008
Identification of small-molecule inhibitors of the colorectal cancer oncogene Krüppel-like factor 5 expression by ultrahigh-throughput screening
AB Bialkowska, M Crisp, T Bannister, Y He, S Chowdhury, S Schürer, ...
Molecular cancer therapeutics 10 (11), 2043-2051, 2011
542011
Synthesis of small molecule inhibitors of the orphan nuclear receptor steroidogenic factor-1 (NR5A1) based on isoquinolinone scaffolds
J Roth, F Madoux, P Hodder, WR Roush
Bioorganic & medicinal chemistry letters 18 (8), 2628-2632, 2008
452008
First-in-Class Inhibitors of Sulfur Metabolism with Bactericidal Activity against Non-Replicating M. tuberculosis
PB Palde, A Bhaskar, LE Pedró Rosa, F Madoux, P Chase, V Gupta, ...
ACS chemical biology 11 (1), 172-184, 2016
432016
Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor
F Yan, Y Yu, DC Chow, T Palzkill, F Madoux, P Hodder, P Chase, ...
PLoS One 9 (4), e95243, 2014
432014
Identification of Potent Inhibitors of the Trypanosoma brucei Methionyl-tRNA Synthetase via High-Throughput Orthogonal Screening
L Pedró-Rosa, FS Buckner, RM Ranade, C Eberhart, F Madoux, ...
Journal of biomolecular screening 20 (1), 122-130, 2015
372015
Modulators of STAT transcription factors for the targeted therapy of cancer (STAT3 activators)
F Madoux, M Koenig, E Nelson, S Chowdhury, M Cameron, B Mercer, ...
Probe Reports from the NIH Molecular Libraries Program [Internet], 2010
372010
Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
F Madoux, D Dreymuller, JP Pettiloud, R Santos, C Becker-Pauly, ...
Scientific reports 6 (1), 11, 2016
362016
A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype
S Kota, S Hou, W Guerrant, F Madoux, S Troutman, V Fernandez-Vega, ...
Oncogene 37 (32), 4372-4384, 2018
352018
A FluoPol-ABPP PAD2 high-throughput screen identifies the first calcium site inhibitor targeting the PADs
DM Lewallen, KL Bicker, F Madoux, P Chase, L Anguish, S Coonrod, ...
ACS Chemical biology 9 (4), 913-921, 2014
332014
Inhibiting AMPylation: a novel screen to identify the first small molecule inhibitors of protein AMPylation
DM Lewallen, A Sreelatha, V Dharmarajan, F Madoux, P Chase, ...
ACS chemical biology 9 (2), 433-442, 2014
302014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20